Therapeutic Areas: Infections and Infectious Diseases | Hepatology (Liver, Pancreatic, Gall Bladder) | Gastroenterology | Immunology
Hepatitis B Clinical Trials
A listing of Hepatitis B medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
California
Garden Grove : Sc Clinical Research, Inc.
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Los Angeles :
Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients
Palo Alto : Stanford University
Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy While on the Orthotopic Liver Transplant (OLT) List
Sacramento : University Of California Davis Medical Center
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
San Diego : University of California Antiviral Research Center (AVRC)
A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B
San Diego : University of California Antiviral Research Center (AVRC)
A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection
San Francisco : University Of California, San Francisco
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
San Francisco : Updated
A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B
Connecticut
Hartford : Connecticut Children'S Medical Center
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
New Haven : Yale University School Of Medicine
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
District of Columbia
Washington : Children'S National Medical Center
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Washington : Georgetown University Hospital
Evaluating Blood Glucose Levels During Infusion With HepaGam B (HBIG) in Post-liver Transplant Patients
Florida
Gainesville : University Of Florida
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Georgia
Stockbridge : Clinical Research Atlanta
Hepatitis B vaccine for adults with type II diabetes.
Atlanta : Romero, Rene
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Atlanta : Atlanta Gastroenterology Associates
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Atlanta :
Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients
Indiana
Indianapolis : Indiana University School Of Medicine / Riley Hospital
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Indianapolis : Indiana University Medical Center
A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B
Indianapolis : Indiana University Medical Center
A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection
Louisiana
New Orleans : Tulane University Health Sciences Center
A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B
New Orleans : Tulane University Health Sciences Center
A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection
Maryland
Baltimore : Johns Hopkins School Of Medicine
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Baltimore : Updated
A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B
Baltimore : Mercy Medical Center
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Bethesda : National Institute of Allergy and Infectious Diseases
A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B
Bethesda : National Institute of Allergy and Infectious Diseases
A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection
Columbia : Gastro Center Of Maryland
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Massachusetts
Boston : Children'S Hospital Of Boston
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Boston : Shah, Uzma
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Boston : Beth Israel Deaconess Medical Center
A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection
Boston : Updated
A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B
Boston : BIDMC
FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy
Boston : Massachusetts General Hospital
Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy While on the Orthotopic Liver Transplant (OLT) List
Michigan
Detroit : Henry Ford Health System
A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B
Detroit : Henry Ford Health System
A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection
Minnesota
Minneapolis :
Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients
Missouri
Kansas City : Kansas City Gastroenterology and Hepatology
A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B
Kansas City : Kansas City Gastroenterology and Hepatology
A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection
St. Louis : Updated
A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B
St. Louis : Bruce Bacon M.D.
FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy
New York
New York : Clinilabs, Inc.
Do you have Hepatitis B?
Flushing : Office Of Sing Chan Md
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Flushing : Medical Procare, Pllc
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
New York : Mount Sinai Medical Center
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
New York : Weill Cornell Medical College
A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B
New York : CliniLabs
A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B
New York : CliniLabs
A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection
New York : Weill Cornell Medical College
A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection
New York : New York School of Medicine
Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection
New York :
Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients
North Carolina
Charlotte : Levine Children'S Hospital At Carolinas Medical Center
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Durham : Duke University Medical Center
FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy
Wilmington : Registry Coordinating Center
Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women.
Ohio
Cleveland : University Hospitals Case Medical Center
A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B
Cleveland : University Hospitals Case Medical Center
A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection
Oregon
Portland : Oregon Health Science University
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Pennsylvania
Philadelphia : Children'S Hospital Of Philadelphia
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Philadelphia : CRI Worldwide, LLC
A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B
Rhode Island
Providence : Rhode Island Hospital
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Tennessee
Texas
Houston : Texas Children'S Hospital
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Houston : Baylor College of Medicine
A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B
Houston : Baylor College of Medicine
A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection
Houston : Texas Children's Hospital
Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection
Utah
Salt Lake City : J. Lewis Research, Inc.
Research study of a Hepatitis B vaccine in adults 20 to 49 years of age, with or without Type 2 Diabetes
Salt Lake City : University of Utah
A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B
Salt Lake City : University of Utah
A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection
Virginia
Fairfax : Inova Fairfax Hospital For Children
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Washington
Seattle : Updated
A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B
Australia
Clayton : Monash University, Department of Medicine
A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B
Clayton : Monash University, Dept. of Medicine
A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection
Herston : Royal Brisbane and Women's Hospital
A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B
Herston : Royal Brisbane and Women's Hospital
A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection
Melbourne : Alfred Hospital, Department of Gastroenterology
A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection
Melbourne : Updated
A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B
Melbourne : The Alfred Hospital
A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infected Patients
Melbourne : The Alfred Hospital
HIV-HBV Co-Infection and Liver Disease
Nedlands : Royal Perth Hospital
A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B
Nedlands : Royal Perth Hospital
A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection
North Adelaide : Updated
A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B
North Ryde : Merck Sharp & Dohme
A Study of the Safety and Efficacy of PEG-Intron™ Versus PEGASYS™ in Participants With Chronic Hepatitis B (P08450 AM1)
Sydney : Updated
A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B
Belgium
Antwerpen : GSK Investigational Site
Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface Antigen (HBsAg) in Combination With a GlaxoSmithKline (GSK) Biologicals' Adjuvant System
Brussels : Updated
A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B
Bruxelles : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Gent : Updated
A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B
Bulgaria
Pleven :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B
Plodiv : University Multiprofile Hospital for Active Treatment "Sveti Georgi"
Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection
Plovdiv :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B
Sofia : Updated
A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B
Sofia :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B
Sofia : Multiprofile Hospital for Active Treatment "Tokuda Hospital"
Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection
Sofia : Novartis Investigative Site
Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept
Stara Zagora :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B
Varna : Updated
A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B
Varna :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B
Varna : Novartis Investigative Site
Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept
Canada
Calgary : University of Calgary, Heritage Medical Research Center
A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B
Calgary : University of Calgary, Heritage Medical Research Center
A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection
Edmonton : University of Alberta Hospital
A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B
Edmonton : University of Alberta Hospital
A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection
Laval : Algorithme Pharma, Inc.
A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection
Montreal : Algorithme Pharma, Inc.
A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B
Montreal :
Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients
Toronto : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
China
Beijing :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Beijing : Local Institution
Effectiveness of Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB Patients in China
Beijing : Beijing Youan Hospital, Capital Medical University
Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B
Beijing : National Center for AIDS/STD Control and Prevention, China CDC
Efficacy and Safety of TDF+3TC+EFV in Adults With HIV/HBV Coinfection
Beijing : People's Hospital Under Beijnig University
EFFORT Extension Study
Beijing : BeiJing YouAn Hospital ,Capital Medical University
EFFORT Extension Study
Beijing : Beijing Ditan Hospita
EFFORT Extension Study
Beijing : Department of Infectious Disease, First Hospital of Peking University
EFFORT Extension Study
Beijing : Beijing Friendship Hospital Attached To The Capital Medical University
EFFORT Extension Study
Beijing : 302 Military Hospital Of China
EFFORT Extension Study
Chang Chun : Hepatobiliary Disease Hospital of Jilin Province
Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus
Changchun :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Changchun : First Hospital .Jilin Unniversity
EFFORT Extension Study
Changsha :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Changsha : Xiangya Hospital Central-South Univrsity
EFFORT Extension Study
Changshu : Local Institution
Effectiveness of Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB Patients in China
Changzhou :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Chengdu : West China Hospital.SiChuan University
EFFORT Extension Study
Chongqing :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Chongqing : Southwest Hospital
Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B
Chongqing : Second Affiliated Hospital Chongqing Medical University
Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B
Chongqing : The Second Affiliated of ChongQing University of Medical Science
EFFORT Extension Study
Chongqing : Southwest Hospital
Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus
Daqing : Local Institution
Effectiveness of Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB Patients in China
Foshan :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Fuzhou :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Fuzhou : Fuzhou Infectious Disease Hospital
Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B
Guangzhou :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Guangzhou : Guangzhou Eighth People's Hospital
Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B
Guangzhou : Department of Infectious Disease, Nanfang Hospital
EFFORT Extension Study
Guangzhou : The Third Hospital of Sun Yat-Sen University
EFFORT Extension Study
Guangzhou : No. 8 People's Hospital In GuangZhou
EFFORT Extension Study
Hangzhou :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Hangzhou : The First Affiliated Hospital of College of Medicine, Zhejiang University
EFFORT Extension Study
Hangzhou : The Sixth People's Hospital of Hangzhou
EFFORT Extension Study
Harbin :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Hong Kong : Department of Medicine, Queen Mary Hospital
Effects of Telbivudine and Tenofovir Disoproxil Fumarate Treatment on the Hepatitis B Virus DNA Kinetics in CHB
Jiangmen :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Jinan :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Jinan : Jinan Infectious Disease Hospital
Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B
Jinan : JiNan Infectious Diseases Hospital
EFFORT Extension Study
Kunming :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Lanzhou : First Affiliated Hospital of Lanzhou University
Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B
Liuzhou :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Nan Jing : The Second Affiliated Hospital of the Southeast University
Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus
Nanchang :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Nanjing :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Nanjing : No.81 Hospital of PLA
EFFORT Extension Study
Nanning :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Nanyang : Nanyang Central Hospital
Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus
Ordos :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Qingdao :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Shanghai :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Shanghai : No.85 Hospital of PLA
EFFORT Extension Study
Shanghai : Shanghai Ruijin Hospital
EFFORT Extension Study
Shanghai : Changhai Hospital affiliated to Second Military Medical University
EFFORT Extension Study
Shanghai : Huashan Hospital，Fudan University
EFFORT Extension Study
Shen Yang :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Shengyang : ShengJing Hospital of China Medical University
EFFORT Extension Study
Shenyang :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Shenyang : Shenyang Sixed People's Hospital
Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B
Shenzhen :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Shi Jiazhuang :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Shijiazhuang :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Shijiazhuang : The Fifth Hospital of Shijiazhuang
Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus
Suzhou :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Taiyuan : First Affiliated Hospital, Shanxi University
Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B
Tianjin :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Tianjin : Tianjin Third Central Hospital
Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B
Urumqi :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Wenzhou :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Wuhan : Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology
EFFORT Extension Study
Wuxi :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Xiamen :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Xian : Tangdu Hospital
EFFORT Extension Study
Xi'an :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Xi'an : Tangdu Hospital, Fourth Military Medical University
Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B
Xi'an : Xijing Hospital
Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B
Yangzhou :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Yichang :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Zhaoqing :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
Zhengzhou : Henan Provincial People's Hospital
Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B
Zhenjiang :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
France
Lyon : Hopital de la Croix Rousse Updated New
A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant
Paris : Consultation d'Accueil, de Soins et d'Orientation (CASO) de Médecins du Monde (MDM)
Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests
Paris : Hopital Cochin CIC de vaccinologie
Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected Patients
Villejuif : Hôpital Paul Brousse Updated New
A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant
Germany
Berlin : Private Practice
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Berlin : Charite CVK
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Berlin : Leberzentrum am Checkpoint
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Bonn : Universitaetsklinikum Bonn
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Duesseldorf : Zentrum für HIV und Hepatitis
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Essen : Novartis Investigative Site
Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept
Frankfurt : Local Institution
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Frankfurt : J.W. Goethe Universitaetsklinikum
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Freiburg : Local Institution
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Hamburg : Local Institution
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Hamburg : ifi Studien und Projekte GmbH
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Hamburg : Universitaetsklinikum Hamburg Eppendorf
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Hamburg : Novartis Investigative Site
Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept
Hannover : Local Institution
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Hannover : Medizinische Hochschule Hannover
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Heidelberg : Universitaetsklinik Heidelberg
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Herne : Gastroenterologische Gemeinschaftspraxis
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Herne : Novartis Investigative Site
Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept
Leipzig :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive or HBeAg-Negative Chronic Hepatitis B
Leipzig : Universitaetsklinikum Leipzig
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Leipzig : Novartis Investigative Site
Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept
Leverkusen : Gemeinschaftspraxis Gastroenterologie
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Mainz : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Mainz : Universitätsmedizin Mainz, I. Med. Klinik und Poliklinik
Peg-interferon ADDed to an Ongoing Nucleos(t)Ide Based Treatment in Patients With Chronic Hepatitis B to Induce Decrease of HBs-Antigen
Muenchen : Klinikum der LMU Grosshadern
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Muenster : Centrum interdisziplinaere Medizin
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Starnberg : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Tuebingen : Universitaetsklinik Tuebingen
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Ulm : Universitaetsklinikum Ulm
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Wuppertal : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Greece
Thesaloniki : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Hong Kong
Kowloon : Princess Margaret Hospital
A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection
New Territories : Tuen Mun Hospital
A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection
Pokfulam : Queen Mary Hospital
A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection
Shatin : Prince of Wales Hospital
A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection
Tai Po : Alice Ho Miu Ling Nethersole Hospital
A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection
India
Chandigarh : School of Public Health, Post Graduate Institute of Medical Education and Research
Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine
Coimbatore : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Guwahati : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Hyderabad : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Vijaywada : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Israel
Haifa : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Haifa : Updated
A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B
Jerusalem : Updated
A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B
Petach Tikva : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Zefat : Updated
A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B
Italy
Bari :
A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253
Bologna : S. Orsola Hospital Updated New
A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant
Cagliari : Ospedale Brotzu Updated New
A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant
Cagliari :
A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253
Castellana Grotte :
A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253
Firenze : Local Institution
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Milano :
A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253
Modena : Liver and Multivisceral Transplant Center, University of Modena and Reggio Emilia Updated New
A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant
Modena : A.O.U. Policlinico Università di Modena e Reggio Emilia
Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients
Napoli :
A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253
Padova : Azienda Ospedialera di Padova Updated New
A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant
Padova :
A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253
Padova : Az. Ospedaliera Universitaria di Padova
Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients
Palermo :
A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253
Pisa : Azienda Ospedaliero Universitaria Pisana
Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients
Roma : Local Institution
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Torino : Molinette Hospital Updated New
A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant
Torino : Updated
A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B
Torino : Az. Ospedaliera S.Giovanni Battista di Torino
Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients
Korea, Republic of
Bucheon : Soon Chun Hyang University Bucheon Hospital
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Busan : Inje University Haeundae Paik Hospital
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Busan : Dong-A University Medical Center
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Busan : Kosin University Gospel Hospital
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Cheonan : Dankook University Hospital
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Chuncheon : Chuncheon Sacred Heart Hospital
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Daegu : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Daegu : Yeungnam University Medical Center
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Daegu : Kyungpook National University Hospital
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Daegu : Kyungpook National University
Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection
Guri : Hanyang University Guri Hospital
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Incheon : Gachon University Gil Hospital, Department of Pediatrics
Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection
Jeju : Jeju National University Hospital
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Seongnam : SKChemicals
A Confirmatory Study of Hepabulin IV in HBsAg Positive Liver Transplantation Recipients
Seoul : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Seoul : Local Institution
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Seoul : Hanyang University Hospital
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Seoul : Inje University Sanggye Paik Hospital
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Seoul : Kangnam Severance Hospital
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Seoul : Kangdong Sacred Heart Hospital
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Seoul : Kangbuk Samsung Hospital
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Seoul : Konkuk University Medical Center
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Seoul : Kyunghee university Medical Center
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Seoul : Severance Children's Hospital
Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection
Seoul : Shinchon Severance Hospital
HBsAg Related Response Guided Therapy
Seoul : Department of clinical pharmacology and therapeutics
Safety and Pharmacokinetics Study of Healthy Male Adults When Repeatedly Administered Through Intravenous Injection
Seoul : The Catholic University of Korea Seoul St. Mary's Hospital
Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy With HB110E
Sungnam : Bundang CHA medical center
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Uijeongbu : Uijeongbu St.Mary's Hospital
A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis B Who Have HBeAg(+)
Uijeongbu : Local Institution
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Wonju : Wonju Christian Hospital
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Yangsan : Busan National University Yangsan Hospital
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Yangsan-si : Pusan National University Yangsan Hospital
Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection
Netherlands
Rotterdam : Erasmus Medical Center
PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B Patients
New Zealand
Grafton : Auckland Clinical Studies
A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B
Grafton : Aukland Clinical Studies
A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection
Poland
Bydgoszcz : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Bydgoszcz : Updated
A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B
Bydgoszcz : Collegium Medicum Uniwersytet im. Mikołaja Kopernika
A Study to Assess DV-601 in Subjects With Chronic Hepatitis B
Bytom :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) Analogues
Gdansk :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) Analogues
Krakow : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Krakow : Updated
A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B
Krakow :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) Analogues
Lancut :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) Analogues
Myslowice :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) Analogues
Poznan : Updated
A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B
Raciborz :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) Analogues
Szczecin : Samodzielny Publiczny Wojewódzki Szpital Zespolony
A Study to Assess DV-601 in Subjects With Chronic Hepatitis B
Warsaw : Wojewódzki Szpital Zakaźny
A Study to Assess DV-601 in Subjects With Chronic Hepatitis B
Wroclaw : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Wroclaw :
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) Analogues
Wrocław : NZOZ Centrum Badan Klinicznych
A Study to Assess DV-601 in Subjects With Chronic Hepatitis B
Romania
Bucharest : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Bucharest : Grigore Alexandrescu Emergency Clinical Hospital for Children
Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection
Bucharest : Fundeni Clinical Institute - Constantinesco
Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection
Bucharest : National Institute of Infectious Diseases
Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection
Constanta : Clinical Infectious Diseases Hospital of Constanta
Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection
Craiova : "Victor Babes" Clinical Hospital of Infectious Diseases and Pneumophtisology
Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection
Iasi : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Timisoara : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Russian Federation
Moscow : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Moscow : Updated
A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B
Novokuznetsk : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Samara :
A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B
St Petersburg :
A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B
St. Petersburg : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Stavropol :
A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B
Spain
Barcelona : Hospital Clinic de Barcelona Updated New
A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant
Barcelona : Novartis Investigative Site
Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept
El Palmar : Novartis Investigative Site
Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept
Taiwan
Changhua : Changhua Christian Hospital
Comparison Between Lamivudine and Entecavir Treatment in Patients
ChiaYi : Chia-Yi Christian
Comparison Between Lamivudine and Entecavir Treatment in Patients
Chia-Yi : Chia-Yi Christine Hospital
Tenofovir in Chronic Hepatitis B With Mild ALT Elevation
Kaohsiung : E-Da Hospital
Tenofovir in Chronic Hepatitis B With Mild ALT Elevation
Taichung : Taichung Veterans General Hospital
Comparison Between Lamivudine and Entecavir Treatment in Patients
Taichung : Taichung Veterans General Hospital
Tenofovir in Chronic Hepatitis B With Mild ALT Elevation
Taipei : Local Institution
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Taipei : National Taiwan University Hospital Department of Internal medicine
Pegasys Plus Entecavir Versus Entecavir Alone for Hepatitis Be Antigen-Positive Chronic Hepatitis B
Taipei : Department of Internal Medicine
Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C
Taipei : Taipei Veterans General Hospital-Division of Gastroenterology, Division of Oncology
Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis B
Taoyuan : Local Institution
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Yunlin County : National Taiwan University Hospital Yun-Lin Branch
Tenofovir in Chronic Hepatitis B With Mild ALT Elevation
Thailand
Bangkok :
A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B
Bangkok : Bhumibol Adulyadej Hospital
Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand
Chantaburi : Prapokklao Hospital
Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand
Chiang Mai :
A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B
Chiang Rai : Chiangrai Prachanukroh Hospital
Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand
Chonburi : Chonburi Regional Hospital
Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand
Khon Kaen :
A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B
Phayao : Phayao Provincial Hospital
Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand
Songkhla :
A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B
Ukraine
Kyiv : Updated
A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B
United Kingdom
Birmingham : University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Updated New
A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant
Birmingham : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Birmingham : Updated
A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B
London : King's College Hospital Updated New
A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant
London : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
London : Updated
A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B